Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2002 | 01-2002 | 10-2001 | 07-2001 | 04-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -134,000 | -44,800 | -1,287,700 | -1,110,800 | -1,052,800 |
| Depreciation Amortization | 58,000 | 27,700 | 197,800 | 543,400 | 104,000 |
| Income taxes - deferred | -1,500 | -900 | -438,900 | -349,800 | -317,600 |
| Accounts receivable | 117,600 | 79,900 | 339,300 | 243,400 | 181,600 |
| Accounts payable and accrued liabilities | -57,100 | -54,600 | -61,700 | -46,900 | -15,600 |
| Other Working Capital | 261,900 | 146,300 | 128,300 | -40,300 | -152,200 |
| Other Operating Activity | -30,400 | -21,500 | 1,217,900 | 773,100 | 1,193,100 |
| Operating Cash Flow | $214,500 | $132,100 | $95,000 | $12,100 | $-59,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 165,900 | 59,400 |
| PPE Investments | -21,800 | -16,600 | -230,800 | -220,200 | -175,200 |
| Net Acquisitions | -4,300 | -3,900 | 68,800 | -25,100 | -48,700 |
| Purchase Of Investment | N/A | N/A | -29,000 | N/A | N/A |
| Sale Of Investment | 30,400 | 6,600 | 222,000 | -2,800 | 500 |
| Other Investing Activity | -260,100 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-255,800 | $-13,900 | $31,000 | $-82,200 | $-164,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -2,000 | -35,800 | N/A | 91,400 |
| Debt Repayment | -3,900 | N/A | N/A | -34,600 | N/A |
| Common Stock Issued | 6,300 | 600 | 40,400 | 33,900 | 32,700 |
| Financing Cash Flow | $2,400 | $-1,400 | $4,600 | $-700 | $124,100 |
| Exchange Rate Effect | -200 | 300 | 700 | -1,500 | -800 |
| Beginning Cash Position | 348,600 | 348,600 | 217,300 | 217,300 | 217,300 |
| End Cash Position | 309,500 | 465,700 | 348,600 | 145,000 | 117,100 |
| Net Cash Flow | $-39,100 | $117,100 | $131,300 | $-72,300 | $-100,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 214,500 | 132,100 | 95,000 | 12,100 | -59,500 |
| Capital Expenditure | -21,800 | -16,600 | -249,200 | -220,200 | -175,200 |
| Free Cash Flow | 192,700 | 115,500 | -154,200 | -208,100 | -234,700 |